Biotechnology News and Research

RSS

Insilico Medicine and Qilu Pharmaceutical partner to develop AI-designed cardiometabolic drugs

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center, today announced a strategic partnership on innovative drug development, leveraging Insilico's proprietary Pharma.AI platform to jointly develop small molecule inhibitors, focusing on specific targets for cardiometabolic disease management.

27 Jan 2026

Astoriom acquires Precision Stability Storage

Astoriom, a global leader in scientific research and consumer product sample stability and biorepository storage, has expanded its sample management capabilities in the US with the acquisition of Precision Stability Storage.

27 Jan 2026

KAIST proposes novel strategy for multifactorial Alzheimer's treatment

Conventional treatments of Alzheimer's disease, one of the most common forms of dementia, have been largely focused on targeting individual pathological features.

27 Jan 2026

Blood protein albumin identified as key defense against deadly black fungus

A new international study published in Nature has identified albumin, the most abundant protein in human blood, as a powerful and previously unrecognized defense against mucormycosis, a rare but often fatal fungal infection.

27 Jan 2026

WuXi Biologics and Hanchorbio enter strategic partnership to advance next-generation bi- and multi-functional fusion protein pipeline

WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc., a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, jointly announced today the signing of a strategic collaboration agreement on the development and manufacturing of multiple next-generation bi-/multi-functional fusion programs from HanchorBio's pipeline.

27 Jan 2026

AI-designed NLRP3 inhibitor receives FDA clearance for Parkinson disease trials

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has recently received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA), intended for the treatment of Parkinson's Disease.

23 Jan 2026

New AI-driven method enables precise design of highly efficient custom enzymes

Enzymes with specific functions are becoming increasingly important in industry, medicine and environmental protection.

23 Jan 2026

New ISSCR guidance charts path for pluripotent stem cell therapies

The International Society for Stem Cell Research (ISSCR) today announced the upcoming release of "Charting the Translational Pathway: ISSCR Best Practices for the Development of Pluripotent Stem Cell (PSC)-Derived Therapies," a new paper highlighting some of the most critical aspects of the ISSCR's breakthrough interactive resource designed to transform how PSC-derived therapies are developed, evaluated, and advanced toward clinical and commercial success.

22 Jan 2026

Proimmune introduces Mastering Immunity 2026 - Shanghai symposium to address key immunogenicity challenges

ProImmune Ltd, a global leader in immunological reagents and services, announced the launch of Mastering Immunity 2026 - Shanghai, an inaugural symposium in China providing practical, real-world guidance to help drug developers manage immunogenicity risk.

21 Jan 2026

Scientists discover why patients with chronic kidney disease die of heart problems

Scientists have discovered an answer to the longstanding mystery of why more than half of patients with chronic kidney disease ultimately die of cardiovascular problems: Their kidneys produce a substance that poisons the heart.

20 Jan 2026

Global Alzheimer’s Platform Foundation announces strategic collaboration and partnership with Spear Bio for the transformative Bio-Hermes-002 study

The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.

From Spear Bio 18 Jan 2026

Researchers discover how Mycoplasma pneumoniae acquires cholesterol from human hosts

A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae-responsible for atypical pneumonia and other respiratory infections-to obtain cholesterol and other essential lipids directly from the human body.

16 Jan 2026

Study reveals how ketogenic diet protects against epilepsy seizures

University of Virginia School of Medicine researchers have revealed how the popular, low-carb ketogenic diet protects against epilepsy seizures and possibly neurodegenerative diseases such as Alzheimer's and Parkinson's.

16 Jan 2026

Gut microbiota analysis offers insights into how ultra processed foods affect health

To gain more knowledge about how ultra-processed food affects us, we need new research methods, claim researchers. Now they are looking to better understand our intestinal flora.

16 Jan 2026

Monolithic photocurable hyaluronic acid patch achieves strong wet adhesion for durotomy repair

Durotomy is a common neurosurgical complication involving a tear in the dura mater, the protective membrane surrounding the brain and spinal cord.

16 Jan 2026

LI-COR's Carbon Node named “Internet of Environment Solution of the Year” in 2026 IoT Breakthrough Awards program

LI-COR announced today that its Carbon Node is the recipient of the "Internet of Environment Solution of the Year" award in the 10th annual IoT Breakthrough Awards program conducted by IoT Breakthrough.

From LICORbio 15 Jan 2026

UC San Diego project aims to bioprint patient-specific transplantable human livers

Liver failure is one of the most serious and deadly medical conditions, claiming thousands of lives each year as patients in the United States wait for a donor organ.

14 Jan 2026

CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatment

Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism. Transthyretin amyloidosis (ATTR) is a progressive disorder involving amyloid deposits of misfolded transthyretin (TTR) proteins.

14 Jan 2026

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab.

14 Jan 2026

New European initiative aims to transform real world Alzheimer’s disease care

Today, the ACCESS-AD consortium is announcing the launch of a transformative European initiative that will accelerate the implementation of scientific innovations for Alzheimer's disease (AD) management in real-world health systems.

13 Jan 2026

Biotechnology News and Research

Insilico Medicine and Qilu Pharmaceutical partner to develop AI-designed cardiometabolic drugs

Astoriom acquires Precision Stability Storage

KAIST proposes novel strategy for multifactorial Alzheimer's treatment

Blood protein albumin identified as key defense against deadly black fungus

WuXi Biologics and Hanchorbio enter strategic partnership to advance next-generation bi- and multi-functional fusion protein pipeline

AI-designed NLRP3 inhibitor receives FDA clearance for Parkinson disease trials

New AI-driven method enables precise design of highly efficient custom enzymes

New ISSCR guidance charts path for pluripotent stem cell therapies

Proimmune introduces Mastering Immunity 2026 - Shanghai symposium to address key immunogenicity challenges

Scientists discover why patients with chronic kidney disease die of heart problems

Global Alzheimer’s Platform Foundation announces strategic collaboration and partnership with Spear Bio for the transformative Bio-Hermes-002 study

Researchers discover how Mycoplasma pneumoniae acquires cholesterol from human hosts

Study reveals how ketogenic diet protects against epilepsy seizures

Gut microbiota analysis offers insights into how ultra processed foods affect health

Monolithic photocurable hyaluronic acid patch achieves strong wet adhesion for durotomy repair

LI-COR's Carbon Node named “Internet of Environment Solution of the Year” in 2026 IoT Breakthrough Awards program

UC San Diego project aims to bioprint patient-specific transplantable human livers

CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatment

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

New European initiative aims to transform real world Alzheimer’s disease care

Biotechnology eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News